www.regonline.co.uk/Malaria2014
Tuesday, 01 July 2014 09:00 -Thursday, 03 July 2014 17:00
Peninsula Square
London
SE10 0DX
United Kingdom
This three day event will discuss aspects of Malaria control, infection and treatment in an informal academic setting. This year there are three main topics for discussion
- Vector Control: Research, Economics and Policy
- Immunology and Vaccination
- Malaria Drug Development and Resistance Control
With plenty of opportunity for networking and debate, this informal international meeting will bring you up to date with current research and thinking regarding Malaria.
www.regonline.co.uk/Malaria2014
This event has CPD accreditation and an open oral and poster session. Abstracts can be submitted on any subject related to Malaria
.
Who Should Attend: Member of Research Institutions, Government bodies, NGOs, International Organizations and Academies and Pharmaceutical R and D
Day 1: Vector Control: Research, Economics and Policy
The WHO estimations on the burden of malaria do not fully reflect the availability of new tools to fight the diseases nor the multiplicity of parasitological, epidemiology and treatment research- as well as the new thinking on financing- that have been taken place in the last decade. In fact 219 million cases of malaria occur every year around the world and 660.000 people still die – mainly in children under the age of 5. Moreover, it is evident that current funding levels do not allow for full implementation of the newest and most effective interventions globally: The Roll Back Malaria Partnership estimates that an annual funding gap of about $2.8 billion will need to be filled in order to to reduce its incidence by 75% and malaria deaths to zero by 2015. This session aims at understanding the scientific, economic and political implications behind the opportunities and hurdles to stop this killing disease and to achieve the Millennium Development Goals targets.
Day 2: Immunology and Vaccination
This session will discuss the mechanisms of immunity and immunopathology in order to facilitate vaccine design and the identification of additional therapies for treatment of severe malaria. There will be plenty of opportunities for debate and networking.
Day 3: Drug Development and Resistance Control
The prevention of anti-malarial drug resistance is of enormous public health importance. It can be assumed that no therapy currently under development or to be developed in the foreseeable future will be totally protective against malaria. This session will discuss the development of new treatments for malaria together with the use of current drugs to limit, insofar as it is possible, any further development of resistance. There will be plenty of opportunity for delegates to present their work and network in an informal atmosphere, with a lot of time given for discussion and debate.
- Possible new controlling measures for the pyrethroid-resistant malaria vectors, Dr Hitoshi Kawada, Associate Professor, Institute of Tropical Medicine, Nagasaki University, Japan
- Development of enantiomerically pure aminoalcohol quinoline derivatives to improve their antimalarial efficiency and assessment of their activity against Plasmodium falciparum in combination with dihydroartemisinin, Dr Catherine Mullié, Assistant Professor , Faculté de Pharmacie, Université de Picardie Jules Verne, France
- TAntibody longevity to malaria vaccine candidate antigens in immuno-epidemiology studies. Dr Freya Fowkes, Head of Malaria and Infectious Disease Epidemiology, Burnet Institute, Australia
- Availability and Affordability of Arthemisinin Combination Therapies: do the subsidies work , Miss Giulia Boselli, Global Health Specialist- Consultant, UK
- Malaria control in coastal areas – special research and policy needs, Professor Ranjan Ramasamy, Visiting Professor, University of Jaffna, Sri Lanka
- Antimalarials that improve immune response, Professor José M. Bautista, Complutense University of Madrid, Madrid, Spain
- Natural products as a source of new drugs and/or herbal treatments for Malaria, Dr Colin Wright, Reader in Pharmacognosy, Bradford School of Pharmacy, University of Bradford, UK
- Malaria control: the nutraceutical potential of natural cocoa powder, Professor Frederick Addai, Academic Researcher, University of Ghana Medical School, Ghana
- Severe malaria episodes inhibit germinal centre reactions and development of humoral immunity, Dr Diana Hansen, Laboratory Head, The Walter & Eliza Hall Institute, Australia
Additional confirmed Speakers include
- Dr Irene Gramaglia, Associate Professor, La Jolla Infectious Disease Institute, United States
- Dr Britta Urban, Liverpool School of Tropical Medicine, United Kingdom
- Dr Joyce M. Velez, La Jolla Infectious Disease Institute, United States
- Dr Pierre Guermonprez, Center for Molecular and Cellular Biology of Inflammation, King’s College London, United Kingdom
- Professor Maria Victoria Valero-Bernal, Universidad Nacional de Colombia, Colombia
- Dr Glenn McConkey, Senior Lecturer, School of Biology, University of Leeds, UK
- Dr Kathy Andrews, Associate Professor, Tropical Parasitology Lab, Griffith University, Australia
- Dr Mohga Kamal-Yanni, Senior health & HIV policy advisor, Oxfam GB
- Mr Aditya Jha, Centre for Cellular and Molecular Biology, India
- Dr Bhargavi Rao, Honorary Clinical Research Fellow, Imperial College London, UK
- Professor Andrew Taylor-Robinson, Professor of Immunology/Haematology & Deputy Dean Research | School of Medical & Applied Sciences CQ University Rockhampton, Queensland, Australia
